Literature DB >> 812750

The treatment of childhood epilepsy with sodium valproate.

D Haigh, W I Forsythe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 812750     DOI: 10.1111/j.1469-8749.1975.tb04698.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


× No keyword cloud information.
  11 in total

1.  Complex partial seizures: EEG foci and response to carbamazepine and sodium valproate.

Authors:  A K Gupta; P M Jeavons
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-10       Impact factor: 10.154

Review 2.  Clinical pharmacokinetics of valproic acid.

Authors:  R Gugler; G E von Unruh
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

Review 3.  Drug level monitoring in paediatric practice.

Authors:  G W Rylance; T A Moreland
Journal:  Arch Dis Child       Date:  1980-02       Impact factor: 3.791

4.  Treatment of childhood epilepsy with dipropylacetic acid (DPA).

Authors:  I Lagenstein; H J Sternowsky; E Blaschke; M Rothe; R Fehr
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-10-09

Review 5.  Therapeutic drug monitoring of anticonvulsants. State of the art.

Authors:  I A Choonara; A Rane
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

Review 6.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 7.  Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-02       Impact factor: 9.546

Review 8.  Concentration-effect relationships of valproic acid.

Authors:  D W Chadwick
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

9.  Sodium valproate and cognitive functioning in normal volunteers.

Authors:  P J Thompson; M R Trimble
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

10.  Continuous sodium valproate or phenobarbitone in the prevention of 'simple' febrile convulsions. Comparison by a double-blind trial.

Authors:  E Ngwane; B Bower
Journal:  Arch Dis Child       Date:  1980-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.